Vivera Pharmaceuticals scores $440m from JR Dallas Wealth Management

Vivera Pharmaceuticals, a pharmaceutical company, has raised $440 million in funding.

30 November 2020•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles